Resources

This policy brief provides an overview of the developing issues and unique mental health and substance use challenges that COVID-19 poses for rural and remote communities.

To explore the implementation and effectiveness of the British Columbia, Canada, risk mitigation guidelines among people who use drugs, focusing on how experiences with the illicit drug supply shap

To describe current approaches in treatment of opioid use disorder (OUD) within Canadian psychosocial outpatient, day, and residential addiction treatment programs, with an emphasis on the use of o

Longitudinal studies suggest that low clinical insight could be linked to more relapse. However, association with successful quit attempts remains unknown.

Following user-centered development and testing phases, a multi-feature smartphone application called HOPE (Heal. Overcome. Persist.

Few persons who initiate MOUD are retained on treatment, thus it is critical to identify factors associated with retention.

This study examined metropolitan and rural differences regarding concerns about opioid misuse and support for different strategies to reduce opioid use disorder risk in areas not designated as high

This study aimed to capture people who use drugs’ (PWUD) lived experiences to understand motivations underlying fentanyl test strip uptake, ongoing use, and actions after testing.

Examine 30-day measures of substance use, overdose experiences, and number of “protected” opioid use events, defined as involving naloxone and the presence of another person who could administer it

This study aims to understand the implications that this has for the life circumstances and risk management of people who use drugs in areas of low access.

This rapid review sought to summarize the retention rates reported by randomized controlled trials (RCTs) and controlled observational study designs that compared methadone to buprenorphine (or bup

Assess whether supervised consumption clients use methadone, or whether their use of methadone prevents opioid overdose.

To examine potentially unsafe tapering and discontinuation among dosage changes in opioid prescriptions dispensed to US patients on high-dose long-term opioid therapy.

We aimed to evaluate the association between benzodiazepine use in the first trimester of pregnancy and the risk of major congenital malformations.

Among recipients of opioid agonist therapy (OAT) in Ontario, Canada, early in the COVID-19 pandemic, was there an association between dispensing of increased take-home doses and treatment retention

Peer Support Responders were trained under the Overdose Prevention & Resuscitation (CPR-OPR) program.

Investigated the impact of the expansion in eligibility for take-home doses on trends in the distribution of take-home doses of OAT during COVID-19.